Isolated antibody to hepatitis B core antigen in patients with chronic hepatitis C virus infection

World Journal of Gastroenterology

Volumn 12, Issue 27, 2006, Pages 4406-4410

  Helmy, Ahmed ^a,b   Al Sebayel, Mohammed Ibrahim ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b Assiut University Faculty of Medicine   (Egypt)

Author keywords

Chronic hepatitis; Cirrhosis; Co infection; Dual infection; Hepatitis B screening; Super infection

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; VIRUS DNA;

ADULT; ANTIBODY DETECTION; ANTIBODY ISOLATION; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE SEVERITY; FEMALE; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS VIRUS; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PREVALENCE; QUALITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE; SUPERINFECTION;

EID: 33746919637     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i27.4406     Document Type: Article

References (25)

1. Lee DS, Huh K, Lee EH, Lee DH, Hong KS, Sung YC. HCV and HBV coexist in HBsAg-negative patients with HCV viraemia: possibility of coinfection in these patients must be considered in HBV-high endemic area. J Gastroenterol Hepatol 1997; 12: 855-861
2. Zarski JP, Bohn B, Bastie A, Pawlotsky JM, Baud M, Bost-Bezeaux F, Tran van Nhieu J, Seigneurin JM, Buffet C, Dhumeaux D. Characteristics of patients with dual infection by hepatitis B and C viruses. J Hepatol 1998; 28: 27-33
3. Pontisso P, Gerotto M, Benvegnu L, Chemello L, Alberti A. Coinfection by hepatitis B virus and hepatitis C virus. Antivir Ther 1998; 3:137-142
4. Mehdi SR, Pophali A, Al-Abdul Rahim KA. Prevalence of hepatitis B and C and blood donors. Saudi Med J 2000; 21: 942-944
5. Memish Z, Qasim L, Abed E, AlBasheer A, Aldraihim A, Knawy B, Hajeer AH. Pattern of viral hepatitis infection in a selected population from Saudi Arabia. Mil Med 2003; 168: 565-568
6. Mohamed Ael S, al Karawi MA, Mesa GA. Dual infection with hepatitis C and B viruses: clinical and histological study in Saudi patients. Hepatogastroenterology 1997; 44: 1404-1406
7. Ghabrah TM, Stickland GT, Tsarev S, Yarbough P, Farci P, Engle R, Emerson S, Purcell R. Acute viral hepatitis in Saudi Arabia: seroepidemiological analysis, risk factors, clinical manifestations, and evidence for a sixth hepatitis agent. Clin Infect Dis 1995; 21: 621-627
8. Hadler SC, Murphy BL, Schable CA, Heyward WL, Francis DP, Kane MA. Epidemiological analysis of the significance of low-positive test results for antibody to hepatitis B surface and core antigens. J Clin Microbiol 1984; 19: 521-525
9. Joller-Jemelka HI, Wicki AN, Grob PJ. Detection of HBs antigen in "anti-HBc alone" positive sera. J Hepatol 1994; 21: 269-272
10. Grob P, Jilg W, Bornhak H, Gerken G, Gerlich W, Gunther S, Hess G, Hudig H, Kitchen A, Margolis H, Michel G, Trepo C, Will H, Zanetti A, Mushahwar I. Serological pattern "anti-HBc alone": report on a workshop. J Med Virol 2000; 62: 450-455
11. Bernvil SS, Andrews V, Kuhns MC, McNamara AL. Hepatitis B core antigen antibody as an indicator of a low grade carrier state for hepatitis B virus in a Saudi Arabian blood donor population. Transfus Sci 1997; 18: 49-53
12. Al-Sebayel MI, Khalaf HA, Ramirez CG. The prevalence of hepatitis B core antibody positivity in donors for liver transplantation in Saudi Arabia. Saudi Med J 2002; 23: 298-300
13. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RN. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-699
14. Gandhi RT, Wurcel A, Lee H, McGovern B, Boczanowski M, Gerwin R, Corcoran CP, Szczepiorkowski Z, Toner S, Cohen DE, Sax PE, Ukomadu C. Isolated antibody to hepatitis B core antigen in human immunodeficiency virus type-1-infected individuals. Clin Infect Dis 2003; 36: 1602-1605
15. Kao JH, Chen PJ, Lai MY, Chen DS. Occult hepatitis B virus infection and clinical outcomes of patients with chronic hepatitis C. J Clin Microbiol 2002; 40: 4068-4071
16. Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med 1999; 341: 22-26
17. Jilg W, Sieger E, Zachoval R, Schatzl H. Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus. J Hepatol 1995; 23: 14-20
18. Ferraro D, Bonura C, Giglio M, Di Stefano R, Almasio PL, Di Marco V, Craxi A, Cacciola I, Squadrito G, Raimondo G. Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C. J Biol Regul Homeost Agents 2003; 17: 172-175
19. Fan CL, Wei L, Jiang D, Chen HS, Gao Y, Li RB, Wang Y. Spontaneous viral clearance after 6-21 years of hepatitis B and C viruses coinfection in high HBV endemic area. World J Gastroenterol 2003; 9: 2012-2016
20. Fabris P, Brown D, Tositti G, Bozzola L, Giordani MT, Bevilacqua P, de Lalla F, Webster GJ, Dusheiko G. Occult hepatitis B virus infection does not affect liver histology or response to therapy with interferon alpha and ribavirin in intravenous drug users with chronic hepatitis C. J Clin Virol 2004; 29: 160-166
21. Giannini E, Ceppa P, Botta F, Fasoh A, Romagnoli P, Ansaldi F, Durando P, Risso D, Lantieri PB, Icardi GC, Testa R. Previous hepatitis B virus infection is associated with worse disease stage and occult hepatitis B virus infection has low prevalence and pathogenicity in hepatitis C virus-positive patients. Liver Int 2003; 23: 12-18
22. Lok AS, Lai CL, Wu PC. Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: implications in hepatitis B vaccination programs. Hepatology 1988; 8: 766-770
23. McMahon BJ, Parkinson AJ, Helminiak C, Wainwright RB, Bulkow L, Kellerman-Douglas A, Schoenberg S, Ritter D. Response to hepatitis B vaccine of persons positive for antibody to hepatitis B core antigen. Gastroenterology 1992; 103: 590-594
24. Piroth L, Binquet C, Vergne M, Minello A, Livry C, Bour JB, Buisson M, Duong M, Grappin M, Portier H, Chavanet P. The evolution of hepatitis B virus serological patterns and the clinical relevance of isolated antibodies to hepatitis B core antigen in HIV infected patients. J Hepatol 2002; 36: 681-686
25. Berger A, Doerr HW, Rabenau HF, Weber B. High frequency of HCV infection in individuals with isolated antibody to hepatitis B core antigen. Intervirology 2000; 43: 71-76